Glenmede Trust’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,099
Closed -$27K 1849
2020
Q3
$27K Sell
2,099
-24
-1% -$309 ﹤0.01% 1500
2020
Q2
$24K Sell
2,123
-2,154
-50% -$24.4K ﹤0.01% 1522
2020
Q1
$116K Hold
4,277
﹤0.01% 1372
2019
Q4
$116K Sell
4,277
-1,882
-31% -$51K ﹤0.01% 1372
2019
Q3
$175 Buy
6,159
+109
+2% +$3 ﹤0.01% 1221
2019
Q2
$167 Hold
6,050
﹤0.01% 1221
2019
Q1
$200 Sell
6,050
-829
-12% -$27 ﹤0.01% 1174
2018
Q4
$199 Buy
+6,879
New +$199 ﹤0.01% 1119
2018
Q3
Sell
-2,345
Closed -$87K 1682
2018
Q2
$87K Sell
2,345
-51
-2% -$1.89K ﹤0.01% 1294
2018
Q1
$81K Hold
2,396
﹤0.01% 1464
2017
Q4
$81K Buy
2,396
+243
+11% +$8.22K ﹤0.01% 1464
2017
Q3
$77K Hold
2,153
﹤0.01% 1490
2017
Q2
$40K Hold
2,153
﹤0.01% 1684
2017
Q1
$40K Buy
2,153
+1,000
+87% +$18.6K ﹤0.01% 1684
2016
Q4
$18K Sell
1,153
-150
-12% -$2.34K ﹤0.01% 1930
2016
Q3
$26K Sell
1,303
-12,101
-90% -$241K ﹤0.01% 1852
2016
Q2
$409K Buy
13,404
+12,054
+893% +$368K ﹤0.01% 986
2016
Q1
$50K Buy
1,350
+35
+3% +$1.3K ﹤0.01% 1518
2015
Q4
$56K Buy
1,315
+32
+2% +$1.36K ﹤0.01% 1530
2015
Q3
$48K Buy
1,283
+4
+0.3% +$150 ﹤0.01% 1598
2015
Q2
$43K Sell
1,279
-462,537
-100% -$15.6M ﹤0.01% 1683
2015
Q1
$16.4M Buy
463,816
+4,266
+0.9% +$151K 0.12% 277
2014
Q4
$15.7M Buy
459,550
+26,366
+6% +$898K 0.12% 261
2014
Q3
$16.7M Buy
433,184
+22,661
+6% +$874K 0.15% 217
2014
Q2
$16M Buy
410,523
+36,362
+10% +$1.41M 0.14% 220
2014
Q1
$12.8M Buy
374,161
+54,478
+17% +$1.86M 0.12% 249
2013
Q4
$6.71M Sell
319,683
-65,708
-17% -$1.38M 0.07% 334
2013
Q3
$8.92M Buy
385,391
+115,983
+43% +$2.68M 0.11% 251
2013
Q2
$7.24M Buy
+269,408
New +$7.24M 0.09% 247